Emmaus Life Sciences, Inc. (OTC:EMMA)
Business/Consumer Services • Computer Services
CIK 822370
Company
Emmaus Life Sciences, Inc. engages in the discovery, development, marketing, and sale of treatments and therapies for rare and orphan diseases. It operates through the Marketing and Sales of Endari segment. The company was founded on March 20, 1987 and is headquartered in Torrance, CA.
Address
21250 Hawthorne Boulevard
Suite 800
Torrance, California 90503
21250 Hawthorne Boulevard
Suite 800
Torrance, California 90503
Employees
55
55
Stock Info
Close
$0.0175
$0.0175
Day Range
0.0172 - 0.0172
0.0172 - 0.0172
52 Week Range
0.0001 - 0.1290
0.0001 - 0.1290
Average volume
46.51K
46.51K
Short Interest
41.22K (08/15/19)
41.22K (08/15/19)
% of Float Shorted
0.12%
0.12%
Market Cap
$1.1M
$1.1M
Revenue
$29.6M
$29.6M
Net Income
-$3.73M
-$3.73M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Director Jon S. Kuwahara |
Independent Director Wei Peu Zen |
Independent Director Ian Zwicker |
SEC filings
Date | Form | Event |
---|---|---|
19 Nov, 2024 | 8-K | |
19 Nov, 2024 | 10-Q | |
14 Nov, 2024 | NT 10-Q | |
6 Nov, 2024 | 8-K | |
25 Oct, 2024 | 8-K | |
9 Oct, 2024 | 3 | |
4 Oct, 2024 | 8-K | |
18 Sep, 2024 | 4 | |
10 Sep, 2024 | 10-Q | |
10 Sep, 2024 | 8-K | |
10 Sep, 2024 | 10-Q | |
15 Aug, 2024 | NT 10-Q | |
17 Jul, 2024 | 8-K | |
3 Jul, 2024 | 10-K | |
3 Jul, 2024 | 8-K | |
28 May, 2024 | 8-K | |
1 Apr, 2024 | NT 10-K | |
29 Feb, 2024 | 4 | |
26 Feb, 2024 | 8-K | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
3 Jan, 2024 | 4/A | |
22 Dec, 2023 | SC 13G | |
21 Dec, 2023 | 4 | |
20 Dec, 2023 | 8-K | |
20 Dec, 2023 | 3/A | |
19 Dec, 2023 | 4 | |
19 Dec, 2023 | 4 | |
4 Dec, 2023 | 4 | |
14 Nov, 2023 | 8-K | |
14 Nov, 2023 | 10-Q | |
4 Oct, 2023 | 8-K | CEO Change |
23 Aug, 2023 | 8-K | |
14 Aug, 2023 | 10-Q | |
14 Aug, 2023 | 8-K | |
2 Jun, 2023 | 4 | |
15 May, 2023 | 8-K | |
15 May, 2023 | 10-Q | |
31 Mar, 2023 | 8-K | |
31 Mar, 2023 | 10-K | |
7 Mar, 2023 | 8-K | |
21 Feb, 2023 | SC 13D/A | |
31 Jan, 2023 | D | |
20 Jan, 2023 | D | |
20 Jan, 2023 | 4 | |
19 Jan, 2023 | 8-K | |
19 Jan, 2023 | 4/A | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
12 Dec, 2022 | 8-K | |
1 Dec, 2022 | 4 | |
15 Nov, 2022 | 8-K | |
14 Nov, 2022 | 10-Q | |
9 Nov, 2022 | SC 13D/A | |
3 Nov, 2022 | 4 | |
31 Oct, 2022 | 4 | |
31 Oct, 2022 | DEF 14A | |
24 Oct, 2022 | 4 | |
21 Oct, 2022 | PRE 14A | |
19 Oct, 2022 | 4 | |
17 Oct, 2022 | 4 | |
13 Oct, 2022 | 4 | |
12 Oct, 2022 | 4 | |
6 Oct, 2022 | 3 | |
6 Oct, 2022 | 8-K | |
6 Oct, 2022 | 3 | |
30 Sep, 2022 | 8-K | |
19 Aug, 2022 | 8-K | |
15 Aug, 2022 | 8-K | |
15 Aug, 2022 | 10-Q | |
10 Aug, 2022 | 8-K | |
25 Jul, 2022 | 4 | |
1 Jul, 2022 | 10-K/A | |
30 Jun, 2022 | D | |
10 Jun, 2022 | 8-K | CEO Change |
3 Jun, 2022 | 4 | |
2 Jun, 2022 | 4 | |
19 May, 2022 | 4 | |
13 May, 2022 | 10-Q | |
13 May, 2022 | 8-K | |
12 Apr, 2022 | 4 | |
31 Mar, 2022 | 8-K | |
31 Mar, 2022 | 10-K | |
2 Mar, 2022 | 4 | |
28 Feb, 2022 | 4 | |
28 Feb, 2022 | 4 | |
23 Feb, 2022 | 4 | |
18 Feb, 2022 | 4 | |
17 Feb, 2022 | SC 13D/A | |
16 Feb, 2022 | 4 | |
11 Feb, 2022 | 4 | |
9 Feb, 2022 | 4 | |
7 Feb, 2022 | 4 | |
24 Jan, 2022 | 3 | |
10 Jan, 2022 | 8-K | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
3 Jan, 2022 | 4 | |
30 Dec, 2021 | S-8 | |
28 Dec, 2021 | 4 | |
28 Dec, 2021 | 3 | |
22 Dec, 2021 | 4 | |
20 Dec, 2021 | 3 | |
17 Dec, 2021 | 4 | |
10 Dec, 2021 | 4 | |
6 Dec, 2021 | 4 | |
2 Dec, 2021 | 4 | |
1 Dec, 2021 | SC 13D/A | |
30 Nov, 2021 | 4 | |
30 Nov, 2021 | 3 | |
30 Nov, 2021 | 4 | |
29 Nov, 2021 | 8-K | |
26 Nov, 2021 | 4 | |
26 Nov, 2021 | 4 | |
23 Nov, 2021 | 4 | |
23 Nov, 2021 | 4 | |
19 Nov, 2021 | 4 | |
12 Nov, 2021 | 10-Q | |
22 Oct, 2021 | 4 | |
12 Oct, 2021 | DEF 14A | |
12 Oct, 2021 | 8-K | |
7 Oct, 2021 | 4 | |
30 Sep, 2021 | PRE 14A | |
29 Sep, 2021 | 4 | |
27 Sep, 2021 | 4 | |
23 Sep, 2021 | 4 | |
17 Sep, 2021 | 4 | |
17 Sep, 2021 | 4 | |
13 Sep, 2021 | 4 | |
10 Sep, 2021 | 4 | |
8 Sep, 2021 | 4 | |
2 Sep, 2021 | 4 | |
1 Sep, 2021 | 10-Q | |
1 Sep, 2021 | 10-Q | |
27 Aug, 2021 | 4 | |
26 Aug, 2021 | 4 | |
26 Aug, 2021 | 10-Q | |
26 Aug, 2021 | 10-Q | |
26 Aug, 2021 | 10-Q | |
23 Aug, 2021 | 4 | |
18 Aug, 2021 | 4 | |
13 Aug, 2021 | 4 | |
10 Aug, 2021 | 8-K | |
10 Aug, 2021 | 4 | |
10 Aug, 2021 | 10-K/A | |
5 Aug, 2021 | 4 | |
2 Aug, 2021 | 4 | |
28 Jul, 2021 | 4 | |
23 Jul, 2021 | 4 | |
22 Jul, 2021 | SC 13D/A | |
20 Jul, 2021 | 4 | |
15 Jul, 2021 | 4 | |
12 Jul, 2021 | 4 | |
7 Jul, 2021 | 4 | |
1 Jul, 2021 | 4 | |
28 Jun, 2021 | 4 | |
22 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
9 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
28 May, 2021 | 4 | |
28 May, 2021 | 4 | |
25 May, 2021 | 4 | |
20 May, 2021 | 4 | |
19 May, 2021 | 8-K | |
17 May, 2021 | NT 10-Q | |
14 May, 2021 | 4 | |
12 May, 2021 | 4 | |
10 May, 2021 | 4 | |
7 May, 2021 | 4 | |
4 May, 2021 | 10-K | |
31 Mar, 2021 | NT 10-K | |
22 Feb, 2021 | 8-K | |
16 Feb, 2021 | 8-K | |
16 Feb, 2021 | D | |
25 Jan, 2021 | 10-K |
Last update:2025-03-06 12:50:37.796477
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.